# Linaclotide for chronic constipation: two 12-week trials

Source: https://pepvault.app/research/linaclotide-trials-303-and-01-2011

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Linaclotide](https://pepvault.app/research#linaclotide)

Randomized trial · people

# Linaclotide beat placebo for chronic constipation in 12-week trials

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In two large placebo-controlled trials, linaclotide helped more people with chronic constipation reach regular bowel movements over 12 weeks, with diarrhea as the side effect that stood out.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 1276
- **Published:** 2011
- **Journal:** N Engl J Med

## What they tested

The teams wanted to know whether linaclotide, taken once a day, works and is safe for people with chronic constipation.

## How the study was done

Two randomized, double-blind, placebo-controlled trials at many centers, together enrolling 1276 patients with chronic constipation. Each patient got placebo (a dummy treatment), the 145 μg arm or the 290 μg arm once a day for 12 weeks.

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The main goal was reaching a weekly target of complete spontaneous bowel movements (CSBMs), along with a rise from each patient's starting level, in at least 9 of the 12 weeks. In Trial 303 and Trial 01, this goal was met by 21.2% and 16.0% in the 145 μg arm and by 19.4% and 21.3% in the 290 μg arm, compared with 3.3% and 6.0% on placebo. Both linaclotide arms also did better than placebo on every secondary measure. Side effects were similar across groups except diarrhea, which made 4.2% of patients in both linaclotide arms stop treatment.

## What it doesn’t show

Each trial lasted only 12 weeks, so long-term risks and benefits were not tested. The trials were funded by Ironwood Pharmaceuticals and Forest Research Institute.

## The paper

Lembo et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011.

- [PubMed (PMID 21830967)](https://pubmed.ncbi.nlm.nih.gov/21830967/)
- [The paper (DOI 10.1056/NEJMoa1010863)](https://doi.org/10.1056/NEJMoa1010863)
- [ClinicalTrials.gov (NCT00730015)](https://clinicaltrials.gov/study/NCT00730015)

## The compound

- [Linaclotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)

## With this study

### Linaclotide

- [Linaclotide: the full reference](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)

### Studies

- [Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTs](https://pepvault.app/research/linaclotide-meine-2026)
- [Linaclotide: bowel prep scores similar to double-dose PEG](https://pepvault.app/research/linaclotide-farag-2025)
- [Linaclotide beat placebo in IBS-C and chronic constipation trials](https://pepvault.app/research/linaclotide-videlock-2013)
- [All 8 studies](https://pepvault.app/research#linaclotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## More studies on Linaclotide

- [Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTs](https://pepvault.app/research/linaclotide-meine-2026) Meta-analysis · people · 2026
- [Linaclotide: bowel prep scores similar to double-dose PEG](https://pepvault.app/research/linaclotide-farag-2025) Meta-analysis · people · 2025
- [Linaclotide beat placebo in IBS-C and chronic constipation trials](https://pepvault.app/research/linaclotide-videlock-2013) Meta-analysis · people · 2013
- [Linaclotide plus 1 L PEG-Asc: 92% vs 86% adequate prep vs senna](https://pepvault.app/research/linaclotide-apple-2025) Randomized trial · people · 2025
- [Linaclotide raised weekly bowel movements in kids with constipation](https://pepvault.app/research/linaclotide-di-lorenzo-2024) Randomized trial · people · 2024
- [Linaclotide: trend to more bowel movements in kids at higher doses](https://pepvault.app/research/linaclotide-di-lorenzo-2024-38533633) Randomized trial · people · 2024
- [Every study on Linaclotide](https://pepvault.app/research#linaclotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Linaclotide

- [Linaclotide: the full reference](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)

### Studies

- [Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTs](https://pepvault.app/research/linaclotide-meine-2026)
- [Linaclotide: bowel prep scores similar to double-dose PEG](https://pepvault.app/research/linaclotide-farag-2025)
- [Linaclotide beat placebo in IBS-C and chronic constipation trials](https://pepvault.app/research/linaclotide-videlock-2013)
- [All 8 studies](https://pepvault.app/research#linaclotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Linaclotide](https://pepvault.app/research#linaclotide)

## The library

- [Linaclotide](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
